by Madaline Spencer | Sep 16, 2025
Alessandro Albuquerque, MD, PhD, Chief Medical Officer of Recordati Rare Diseases North America, discusses unmet needs of patients with Cushing’s syndrome. Cushing’s syndrome is a rare endocrine disorder caused by prolonged exposure of the...
by Madaline Spencer | Sep 15, 2025
Jui-En Lo, MD, Resident of Internal Medicine at MetroHealth, discusses trends and social determinants of teprotumumab in thyroid eye disease (TED). TED is a rare autoimmune disease that can dramatically impact a person’s vision. The condition often...
by Madaline Spencer | Sep 12, 2025
Aliya Aziz Khan, MD, Clinical Professor of Medicine McMaster University and Director of the Calcium Disorder Clinic, discusses long-term safety and efficacy results of palopegteriparatide in patients with hypoparathyroidism. Hypoparathyroidism is an endocrine...
by Madaline Spencer | Sep 11, 2025
Shaishav Dhage, MD, Endocrinologist at The Christie Hospital, discusses a case report on a patient with alemtuzumab-induced thyroid eye disease (TED). TED is a rare autoimmune disease that can dramatically impact a person’s vision. The condition often occurs in...
by Madaline Spencer | Sep 10, 2025
Mona Al Mukaddam, MD, Director of the Penn Bone Center at the University of Pennsylvania, discusses fibrodysplasia ossificans progressiva (FOP). FOP is a disorder in which skeletal muscle and connective tissue are gradually ossified. This condition leads...
